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Contrast enhanced ultrasound molecular imaging of the inflammatory response
in myocarditis
DC. Schmutzler1; E. Khanicheh1; L. Xu2; M. Mitterhuber2; K. Glatz3; E. Ellertsdottir2;
BA. Kaufmann1
1University Hospital Basel, Cardiology, Basel, Switzerland; 2University Hospital Basel,
Department of Biomedicine, Basel, Switzerland; 3University Hospital Basel, Pathology,
Basel, Switzerland
Purpose: Cardiac tests for diagnosing myocarditis lack sensitivity or specificity. We
hypothesized that contrast enhanced ultrasound molecular imaging (CEUMI) could
detect endothelial inflammation and the recruitment of specific cellular components of
the inflammatory response in murine myocarditis.
Methods: Microbubbles (MB) bearing antibodies targeting lymphocyte CD4 (MBCD4),
endothelial P-Selectin (MBPSel), MBwith a control antibody (MBCtr) andMBwith a nega-
tive electrical charge for targeting of leukocytes (MBN) were prepared. Attachment of
MBCD4 was validated in vitro with murine spleen CD4+ lymphocytes. 20 mice were
studied after induction of autoimmune myocarditis by immunisation with a-myosin-
peptide, 20 mice served as controls. CEUMI of the heart was performed with MBCD4,
MBPSel, MBN, and MBCtr. Left ventricular ejection fraction (LVEF) and circumferential
strain (CS) were measured. A pathologist blinded to all other data graded the severity
of myocarditis on a scale from 0 (no myocarditis) to 4 on histology. Animals were
grouped into NM (no myocarditis), MM (moderate myocarditis, score 1-2) and SM
(severe myocarditis, score 3-4).
Results: In vitro, attachment of MBCD4 to CD4+ lymphocytes was significantly greater
than MBCtr (p,0.01). LVEF did not differ between groups (NM 71+13%, MM 73+
7%, SM 62+20%, p=0.5), nor did CS (NM 36+9%, MM 25+11%, SM 30+7%,
p=0.4). CEUMI (figure) showed increased signal for targeted MB vs MBCtr in MM and
SM, whereas signals in NM did not differ from MBCtr.
Conclusions: CEUMI can detect endothelial inflammation and leukocyte infiltration in
myocarditis, while functional imaging fails to do so. In particular, imaging of CD4+ lym-
phocytes involved in autoimmune responses in myocarditis is possible. CEUMI may be
a powerful method for assessing myocarditis.
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Molecular imaging of inflamed atherosclerotic plaque with 18F-anti-VCAM-1
nanobody and PET/CT
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T. Lahoutte4; B. Cosyns1; S. Hernot2
1University Hospital (UZ) Brussels, Centrum voor Hart-en Vaatziekten - CHVZ, Brussels,
Belgium;2FreeUniversityofBrussels (VUB), InVivoCellular andMolecular Imaging–ICMI,
Brussels, Belgium; 3Ghent University, iMinds-IBiTech-MEDISIP, Department of Electronics
and Information Systems,, Ghent, Belgium; 4University Hospital (UZ) Brussels, Nuclear
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Purpose: Vascular cell adhesionmolecule-1 (VCAM-1) is expressed in inflammatory ath-
erosclerotic lesions and is a potential target for the molecular imaging of vulnerable
plaques. A mouse/human cross-reactive anti-VCAM-1 nanobody (Nb) radiolabeled with
99mTc has previously demonstrated to allow detection of VCAM-1 positive plaques
using SPECT/CT. Because of its superior spatial resolution, higher sensitivity, and more
accurate quantification, Positron Emission Tomography (PET) is more appropriate for
clinicaluse.Therefore,weaimed tovalidate the18F-labeledanti-VCAM-1Nbasapotential
PET tracer and show its ability to image VCAM-1 expression byPET/CT in amousemodel
of atherosclerosis.
Methods: The anti-VCAM-1 Nb (cAbVCAM1-5) was labeled using the prosthetic group
N-succinimidyl-4-18F-fluorobenzoate (18F-SFB) and purified by size exlusion chroma-
tography. In vitro cell binding studies using TNF-a stimulated bEND5 cells were carried
out to assess the functionality of the tracer. In vivo mPET/CT imaging was performed at
2h30 post-injection using 20-30 weeks-old ApoE2/2 mice on a Western diet (Group 1)
and normally fed C57BL6 control mice (n=3 per group), which were injected with
18F-anti-VCAM-1 Nb. To demonstrate the specificity, additional ApoE2/2 mice were
injected with 18F-labeled non-targeting control Nb or with 70-fold excess of unlabeled
anti-VCAM-1 Nb. Ex-vivo evaluation (n=6 per group) of plaque uptake in different aorta
segmentsbasedon lesion-extension indexwasassessedbyusinggammawell counting.
Results: After 18F-labeling (radiochemical purity .99%), 18F-labeled anti-VCAM-1 Nb
showed significantly more binding to VCAM-1 positive cells compared to negative cells.
Atherosclerotic lesions in theaortic archofApoE2/2mice injectedwith18F-anti-VCAM-1
Nb were successfully identified using mPET/CT imaging, while background signal was
observed in the aortic arch of the control groups. These results were confirmed by ex
vivo analysis where uptake of 18F-anti-VCAM-1 Nb was significantly higher compared
to control groups and increased with the lesion-extension index (score 0: 0.68+0.10,
score 1: 1.18+0.36, score 2: 1.49+0.37, score 3: 1.48+0.38 %ID/g). In the Group 1,
lesion-to-heart and lesion-to-blood ratios were high (11.2 and 3.13, respectively).
Conclusion:Mouse/human18F-anti-VCAM-1Nballows non-invasivePET/CT imagingof
VCAM-1 expression in atherosclerotic plaques in a mouse model and may represent an
attractive tool for imaging vulnerable atherosclerotic plaques in patients.
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Strain and strain rate correctly identify myocardial dysfunction in advanced
glycation end products (AGEs) injected rats
V. Ferferieva1; D. Deluyker1; T. Arslan1; I. Lambrichts2; JM. Rigo1; V. Bito1
1Hasselt University, Department of physiology, BIOMED, Diepenbeek, Belgium; 2Hasselt
University, Department of morphology, BIOMED, Diepenbeek, Belgium
Purpose: Advanced glycation end products (AGEs) are known to play a key role in the
development and progression of cardiovascular diseases, however, the precise under-
lying mechanism still remains elusive. The study was therefore established to identify
the role of AGEs in the pathophysiology of heart failure.
Methods: 13Sprague-Dawley rats underwent a daily injection of 20mg/kgBSA-modified
AGEs (n=9) or control-BSA (n=4) for 6weeks. 2D echo at baseline (BL) and 6w follow-up
was used to calculate LV dimensions, volumes (EDV, ESV) and sphericity index (SI). Cir-
cumferential strain (Scirc) and strain rate (SRcirc) were obtained at mid-ventricular level
using speckle tracking imaging (STI). LV fibrosiswasmeasuredusingSiriusRed staining.
Results:After AGEs injection, a progressive LV remodeling was observedwith increased
posterior and anterior wall thicknesses, along with higher EDV, ESV and SI compared to
BL (0.26+0.1mL vs 0.15+0.02mL; 0.09+0.05mL vs 0.04+0.01mL and 0.3+0.04
vs 0.18+0.03 p,0.05). Ejection fraction and fractional shortening did not change over
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time, whereas both systolic Scirc/SRcirc were significantly decreased (-16.4+1.8 vs
-21.6+2.7% and -4.7+1.0 vs -6.7+0.7 1/s, p,0.05). Myocardial fibrosis was signifi-
cantly increased compared to BSA-injected animals and was associated with decreased
Scirc/SRcirc (figure1).
Conclusion: AGEs injection was associated with prominent cardiac remodelling and
increased myocardial fibrosis. STI-derived S/SRcirc correctly detect myocardial dys-
function secondary to increased AGEs and might be useful parameters to monitor the
effect of new therapeutic strategies preventing the myocardial dysfunction associated
with AGEs.
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Structural and functional Right Ventricular remodeling is related to training
intensity in an experimental model of endurance exercise
M. Sanz1; M. Sitges1; B. Bijnens2; C. Rubies3; M. Batlle3; LL. Mont1; J. Brugada1;
E. Guasch1
1Barcelona Hospital Clinic, Barcelona, Spain; 2ICREA, Institucio´ Catalana de Recerca i
Estudis Avanc¸ats, Barcelona, Spain; 3Institute of Biomedical Research August Pi Sunyer
(IDIBAPS), Barcelona, Spain
Background:Recent data has shown specific remodeling of the right ventricle (RV) in re-
sponse to chronic training, especially in endurance sport. However, it is not known if this
adaptation is related to the intensity of training or if there is a threshold for developing this
adverse remodeling beyond the normal physiologic response. The aim of this study was
to use an animal model to evaluate the relationship between RV remodeling and intensity
of training.
MethodsandResults:36Wistar ratswere conditioned to rundaily in a treadmill at amod-
erate (Mod, 45 min at 30cm/s) or vigorous (Vig, 60 min at 60cm/s) intensity for 16 weeks;
Sedentary rats (Sed) served as controls. Echocardiography was performed at the 16th
week. Analysis consisted on standard echocardiography of both ventricles,including
dimensions, systolic and diastolic function and Tissue Doppler Imaging echocardio-
graphic assessment of the RV.Both ventricles similarly dilated (roughly 15%) after Mod
training. Mod rats developed improved RV function by increasing RV apical
function, whithout changes in LV function. With Vig training, though, a decline in RV mid-
basal systolic function,RV diastolic function and a disproportionally enlarged RV were
observed.
Conclusion: In this animal model, moderate endurance exercise caused favourable re-
modeling of the RV. However, vigorous training caused a deleterious remodeling, with
RV dilatation, decreased contractility and worse diastolic function. Our finding suggests
that there might be a threshold with intense training from which cardiac adaptation
might start to be deleterious. Whether these changes are reversible should be
further investigated.
Abstract 333 Table. RV and LV measures in the 3 groups
Group Sed
N=17
GroupMod
N=19
GroupVig
N=17
Anova Test
(p)
RVDA(mm2/g) 69,5+8,8 80,4+9,6 88,0+9,2 ,0,01
RV mid-apical free wall
SR (s-1)
2,9+0,5 3,3+0,6 3,0+0,4 0,04
RV basal free wall SR (s-1) 3,3+0,8 3,3+0,7 2,7+0,6 0,04
RVIRT /HR ((ms.min/
beats)x100)
4,2+0,9 4,3+1,0 5,3+1,4 0,03
LVDd (mm/g) 15,3+2,0 18,3+1,4 18,5+1,6 ,0,01
LVEF (%) 78,6+4,6 79,6+1,6 80,7+1,4 0,14
LVIRT /HR ((ms.min/
beats)x100)
4,7+1,0 5,0+1,0 5,2+1,0 0,32
RVDA: Right Ventricular end-Diastolic AreaRVIRT: Right Ventricular Isovolumetric Relaxation
TimeLVIRT : Left Ventricular Isovolumetric Relaxation Time
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